Lv3
316 积分 2024-08-26 加入
Protein‐Targeted Glycan Editing on Living Cells Disrupts KRAS Signaling
1个月前
已完结
Single‑Dose Pharmacokinetics and Safety of the Oral Galectin‑3 Inhibitor, Selvigaltin (GB1211), in Participants with Hepatic Impairment
1个月前
已完结
Discovery of the GSH responsive “Y-PROTACs” targeting ALK and CDK4/6 as a potential treatment for cancer
2个月前
已完结
Discovery of 2,4-diarylaminopyrimidine derivatives bearing sulfonamide moiety as novel FAK inhibitors
2个月前
已完结
Targeting focal adhesion kinase (FAK) for cancer therapy: FAK inhibitors, FAK-based dual-target inhibitors and PROTAC degraders
2个月前
已完结
Small Molecule–Drug Conjugates Emerge as a New Promising Approach for Cancer Treatment
3个月前
已完结
Development and therapeutic potential of GSPT1 molecular glue degraders: A medicinal chemistry perspective
5个月前
已完结
皖公网安备34019202002308
